AXSM (Axsome) Net Profit

AXSM (Axsome Therapeutics, Inc.) - company brandmark

Axsome Therapeutics (AXSM) possesses significant pricing power through the development of indispensable depression treatments. The company is implementing automation in packaging and digital validation of clinical data. The company's total profit demonstrates the fundamental resilience of the business, and -0.19 determines the current status of the parameter, confirming management's skill in transforming an R&D startup into a profitable pharmaceutical asset.

AXSM - Axsome Therapeutics Company Net Income over the range 07/04/2022 - 10/29/2026

Analytical breakdowns and data insights for company Axsome Therapeutics, Inc. (AXSM)

- stock value and consensus price forecast:
Market Price Axsome Corp|AXSM - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Axsome Corp|AXSM - Real Price to Acquire Entire Company
- book capitalization data:
Equity per Share Axsome Therapeutics|AXSM - Company Book Value|Market Capitalization to Book Value axsome.com|AXSM - Aggregate Company Assets
- debt and solvency information:
Debt to Capital Axsome Therapeutics|AXSM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Axsome|AXSM - Company Aggregate Debts|Debts to Book Value Axsome Corp|AXSM - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Axsome Therapeutics|Intermediate Liquidity Ratio axsome.com
- earnings and market ratios statistics:
AXSM - Net Profit
Fundamental valuation:AXSM Axsome Corp
Signature product of Axsome Therapeutics Inc

Daily net profit measures the fundamental resilience of the business, capturing the actual financial result and the issuer's margin of safety in stress scenarios. By analyzing the operating results of Axsome Therapeutics (AXSM), an investor can see the impact of outsourcing the production of neurological drugs on margins, as the absence of proprietary plants minimizes capital expenditures and environmental costs, directly reflecting in the final calculated profit levels.

Key competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Profit regencellbioscience.com|Net Income ACAD (ACADIA Pharmaceuticals Inc.)|Xenon Pharmaceuticals Inc. - Company Profit|Company Net Income Viking Pharma VKTX|Net Financial Result Supernus Corp (SUPN)|CPRX - Company Net Income|Company Net Income denalitherapeutics.com|Harmony Biosciences Holdings, Inc. (HRMY) - Company Net Income|Net Income Biohaven Ltd|AMLX (Amylyx) - Net Profit|Company Net Income Trevi Corp TRVI|Net Income PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Final Profit|CeriBell - Net Income|Profit After Payment of Taxes PRTA (Prothena Corp)|Alector Therapeutics - Net Profit|Final Profit ANNX (Annexon Biosciences Inc.)|OMER: Net Profit|Company Net Income neurogene.com (NGNE)|Company Net Income AC Immune SA|VYGR: Final Profit|Net Profit NMRA|Net Profit Scilex Holding Company, Inc. (SCLX)|Company Net Income Tevogen Bio Holdings TVGN|ACOG (Alpha Cognition Inc) - Profit After Tax|Cognition Therapeutics - Net Profit|Company Net Income Inhibikase Therapeutics Inc|SAVA (Cassava) - Net Income|Assertio (ASRT) - Net Profit|Net Income COYA|VTGN (VistaGen Therapeutics Inc) - Profit After Payment of Taxes|Net Profit OVID|Net Financial Result Acumen Pharmaceuticals Inc.|Net Profit CRVO (CervoMed Inc)|ATHE - Net Income|CLNN - Company Net Income|Net Financial Result PepGen Inc. PEPG|JUNS: Net Profit|Relmada Therapeutics Inc (RLMD) - Net Profit|Net Income ANVS|Company Profit GRCE (Grace Tx)|Company Net Income Firefly Neuroscience, Inc (AIFF)|Net Financial Result anewmeds.com|Company Net Income NeuroSense Therapeutics Ltd. NRSN|RVPH - Net Income|MTVA - Company Net Income|NRXS (NeurAxis Inc) - Company Profit|HSDT: Net Profit|Company Net Income Passage Bio (PASG)|Net Income NEUP|Net Profit Minerva Neurosciences Inc|Company Net Income Athira (ATHA)|ADXN (Addex) - Final Profit|Company Net Income Alzamend Neuro ALZN|Cyclerion Therapeutics Inc. (CYCN) - Company Net Income|Protagenic - Net Profit|KTTA - Net Profit|CRGT (cortigent.com) - Net Income|Company Profit ATXI|Company Net Income Brainstorm Cell|caratherapeutics.com (CARA) - Net Financial Result|Company Net Income Chromocell Therapeutics Corp. (CHRO)|ELYM - Company Net Income|Company Net Income Intra-Cellular Therapies, Inc. ITCI|LBPH - Net Income|Marinus Pharmaceuticals - Net Profit|Company Net Income nkgenbiotech.com|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net Income|Sage Therapeutics Inc. - Final Profit|Net Income SNPX|TRVN (Trevena Inc) - Profit After Payment of Taxes|Net Profit VIGL|WENA (Anew Medical Inc.) - Final Profit|Net Profit CERE (Cerevel Therapeutics, Inc.)